Mycophenolic Acid Delayed Release Tablets USP 360 mg

Mycophenolic Acid Delayed Release Tablets USP 360 mg contain Mycophenolic Acid 360 mg, an immunosuppressive medicine used to help prevent organ rejection in patients who have received a kidney transplant. It is commonly prescribed in combination with other immunosuppressive medications such as tacrolimus or cyclosporine and corticosteroids to reduce the risk of transplant rejection.

The delayed-release formulation is specially designed to release the active ingredient in the intestine rather than the stomach, helping improve gastrointestinal tolerability while maintaining effective immunosuppressive action. Mycophenolic Acid works by inhibiting the proliferation of T and B lymphocytes, reducing the immune system’s response to the transplanted organ.

Manufactured under stringent quality standards, Mycophenolic Acid Delayed Release Tablets USP 360 mg offer consistent quality, safety, and efficacy. The product is supplied by trusted pharmaceutical exporters in India to hospitals, pharmacies, distributors, and healthcare institutions across regulated and semi-regulated international markets.

Patients should take this medicine exactly as prescribed by their healthcare provider. Regular monitoring of kidney function, liver function, complete blood count (CBC), and overall health is recommended throughout treatment to ensure optimal therapeutic outcomes.

As a reliable pharmaceutical exporter from India, we provide Mycophenolic Acid Delayed Release Tablets USP 360 mg with export-grade packaging, complete regulatory documentation, competitive pricing, and dependable worldwide shipping.